This topic contains a solution. Click here to go to the answer

Author Question: Aripiprazole acts as a(n) ______________ in the mesolimbic system and as a(n) ____________ in the ... (Read 23 times)

craiczarry

  • Hero Member
  • *****
  • Posts: 527
Aripiprazole acts as a(n) ______________ in the mesolimbic system and as a(n) ____________ in the prefrontal cortex.
 
  a. agonist; antagonist
  b. antagonist; agonist
  c. agonist; agonist
  d. antagonist; antagonist
  e. partial agonist; partial antagonist

Question 2

Positive and negative schizophrenia symptoms are shown by humans after ingestion of
 
  a. alcohol.
  b. haloperidol.
  c. phencyclidine.
  d. chlordiazepoxide.
  e. a low dose of cocaine.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Anna

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Answer: b. antagonist; agonist

Answer to Question 2

Answer: c. phencyclidine.




craiczarry

  • Member
  • Posts: 527
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


blakcmamba

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library